More information with a small amount of samples! Get the overall picture of potency with just one assay.
"Stunner" is a system that allows simultaneous acquisition of UV/Vis concentration, dynamic light scattering (DLS), and static light scattering (SLS) data from a 2μL identical sample. It enables detailed investigation of AAV to measure total capsid titer and Empty/Full ratio, as well as to obtain payload concentration and size data for any nanoparticles all at once. It is possible to analyze concentration, hydrodynamic size, polydispersity, and the presence of aggregates collectively, allowing for the assessment of protein quality, and you can instantly determine whether your AAV, nanoparticles, or proteins are suitable for your purposes. 【Features】 ■ More information from a small amount of sample ■ Detailed analysis of AAV ■ Supports large-scale nanoparticle size measurements ■ Remarkably excellent data ■ Compatible with downstream applications *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 ■ No sample preprocessing or dilution is required; simply set 2μL of the sample on the plate for analysis. ■ If processing a large volume, it is also possible to connect to a robot to enhance performance. ■ You can check the capsid titer and Empty/Full ratio at your preferred frequency. ■ Free from complex degradation workflows, expensive dyes, and unnecessary calibration curves. ■ The dynamic range covers from 0.02 to 200 mg/mL (mAb). *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog(1)
Download All CatalogsCompany information
Raifiks Analytical Co., Ltd. conducts sales activities nationwide, primarily focusing on pharmaceutical companies. Therefore, we can propose products that align with the latest model information and trends. We offer suggestions for equipment suited to each department, from the drug discovery phase, where unique medications not available from other companies are developed, to production and manufacturing. Our network extends overseas, allowing us to propose products not available through Japanese distributors and to suggest the development of products that do not currently exist in the market. We will provide solutions tailored to our customers' needs.